Moderna exercises option to license proprietary targeting technology from Autolus

October 12, 2022

https://www.globenewswire.com/news-release/2022/10/12/2532713/0/en/Moderna-exercises-option-to-license-proprietary-targeting-technology-from-Autolus.html

– Option exercised on undisclosed immune-oncology target following evaluation period by Moderna –

– Autolus receives option exercise fee, with potential for development milestone payments plus royalties –

Read more at globenewswire.com

Related news for (AUTL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.